Difference between revisions of "Example orders for High-dose Methotrexate (MTX) & Ifosfamide in lymphoma"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "font-size:200%"> Hello!<br>  We're happy that you've chosen to use HemOnc.org, and hope that you will return often. From now until January 31, we are conducting a survey to learn more about our users and how we can make the site better and more useful.<br>  Please help us by filling it out!<br>" to "font-size:300%"> Just 10 days left to fill out a survey on how we can make HemOnc.org better and more useful.<br>")
m (Text replacement - "Just 10 days left" to "Just 9 days left")
Line 1: Line 1:
 
{|style="width: 100%; border-left:solid 20px #dc143c;border-right:solid 20px #dc143c;border-top:solid 20px #dc143c;border-bottom:solid 20px #dc143c;" align="center"  
 
{|style="width: 100%; border-left:solid 20px #dc143c;border-right:solid 20px #dc143c;border-top:solid 20px #dc143c;border-bottom:solid 20px #dc143c;" align="center"  
 
|
 
|
<span style="font-family:Arial; font-size:300%">&nbsp;Just 10 days left to fill out a survey on how we can make HemOnc.org better and more useful.<br>
+
<span style="font-family:Arial; font-size:300%">&nbsp;Just 9 days left to fill out a survey on how we can make HemOnc.org better and more useful.<br>
 
&nbsp;'''Link:''' http://j.mp/2BlBaoQ
 
&nbsp;'''Link:''' http://j.mp/2BlBaoQ
 
</span>
 
</span>

Revision as of 14:25, 23 January 2018

 Just 9 days left to fill out a survey on how we can make HemOnc.org better and more useful.
 Link: http://j.mp/2BlBaoQ


Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer. If this is your first time visiting, we suggest you read the tutorial.

Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature.


High-dose Methotrexate (MTX) & Ifosfamide

Original references may be found at High-dose Methotrexate (MTX) & Ifosfamide

Example regimen #1

  • Methotrexate (MTX) 4000 mg/m2 IV over 4 hours on day 1
    • Do not start methotrexate until urine pH is at least 8 or higher. Admix with sodium bicarbonate.
  • Sodium bicarbonate 25 mEq IV once on day 1, admix with methotrexate
  • Ifosfamide (Ifex) 2000 mg/m2 IV over 3 hours on days 3-5
  • Mesna (Mesnex) 500 mg/m2 IV every 3 hours x 4 doses per day on days 3-5 with ifosfamide
    • Times for mesna in relation to start of ifosfamide; Dose 1 of mesna is at time at 0, dose 2 is 3 hours after start of ifosfamide, dose 3: 6 hours after start of ifosfamide, dose 4: 9 hours post ifosfamide.
  • Folinic acid (Leucovorin) 50 mg IV every 6 hours, starting on day 2
    • To begin 24 hours after the start of day 1's methotrexate infusion and continue for at least 8 doses. Discuss changes such as potential transition to PO leucovorin with MD according to MTX levels.

Supportive medications

  • Ondansetron (Zofran) 8 mg IV on days 1 to 5, 30 minutes prior to chemotherapy
  • Dexamethasone (Decadron) 8 mg IV BID on days 1 to 5
  • Ondansetron (Zofran) 4-8 mg IV Q8H prn nausea
  • Prochlorperazine (Compazine) 10 mg PO Q6H prn nausea

Hydration:

  • 150 mEq sodium bicarbonate in 1000 mL D5W, continuous at 125 mL/H, start on day 1 hours before methotrexate infusion for urine alkalinization. Continue fluids unless discussed otherwise with MD.

Monitoring:

  • Check methotrexate levels 24, 48, and 72 hours after completion of methotrexate infusion.
  • Check urine pH every 4 hours and notify physician if urine pH <8

Clinical scenario & comments:

  • 54 year-old gentleman with stage IV diffuse large B-cell lymphoma with extranodal disease (primary testicular lymphoma), with progression after 6 cycles of R-CHOP. He only received treatment with high-dose methotrexate & ifosfamide for one cycle; treatment was complicated by acute kidney injury, with subsequent improvement back to baseline. This was followed with R-ICE therapy, with disease remission achieved and subsequent allogeneic stem cell transplant.